Clinically Studies on Treatment of Pulmonary Arterial Hypertension Induced Right Heart Failure | Zendy

Yu Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinically Studies on Treatment of Pulmonary Arterial Hypertension Induced Right Heart Failure

Author(s) -

Yu Wang

Publication year - 2015

Publication title -

advanced emergency medicine

Language(s) - English

Resource type - Journals

ISSN - 2315-456X

DOI - 10.18686/aem.v4i1.7

Subject(s) - medicine , heart failure , right heart failure , cardiology , dobutamine , right heart , case fatality rate , pulmonary hypertension , heart rate , hemodynamics , blood pressure , epidemiology

Objective: to study a clinical treatment of pulmonary arterial hypertension induced right heart failure. Method: A total of 60 cases of pulmonary heart disease right heart failure patients were randomly divided into observation group and control group in which 30 cases for each group. Results: In the observation group of 30 cases, 14 cases produce an effect, 15 cases is effective, 2 cases is invalid and the total effective rate is 96.6%. In the control group of 30 cases, 8 cases produce an effect, 17 cases is effective, 5 cases is invalid and the total effective rate is 83.3%. Conclusion: Dobutamine can alleviate symptoms of heart failure, reduce heart failure patients’ fatality rate and improve prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research